RecruitingNCT05391217

Feasibility of Remote Activity Assessment and PRO Collection Among Transgender Cancer Survivors

Study to Remotely Monitor Activity in Transgender Cancer Survivors


Sponsor

Cedars-Sinai Medical Center

Enrollment

20 participants

Start Date

Feb 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective observational feasibility study to evaluate the role of wearable activity monitors to determine the feasibility and acceptability of remote monitoring using wearable technology and PROs to monitor fatigue and physical function in transgender cancer patients and survivors.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • Self-identifies as transgender person with a history of cancer or receiving treatment for cancer in the last five years from screening for the current study (case) OR self-identifies as transgender person without a history of cancer (control)
  • years or older
  • Ambulatory (use of walking aids, such as cane and rollator, is acceptable)
  • Access to a device (e.g., smartphone, tablet, iPhone) that has the capability to sync to the Fitbit
  • Have an understanding, ability, and willingness to fully comply with study procedures and restrictions
  • Can read and understand English, Spanish, or Tagalog (for participant surveys and interviews)
  • Informed consent obtained from subject and ability for subject to comply with the requirements of the study.

Exclusion Criteria2

  • Any person that does not meet the listed criteria above
  • Using a pacemaker, implantable cardiac defibrillator, neurostimulator, implantable hearing aids, cochlear implants, or other electronic medical equipment*. However, removable hearing aids are permitted.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRemote assessment of patient reported outcomes and daily activity

Electronic patient-reported outcomes (NIH PROMIS) will be collected and combined with remotely monitored physical activity, heart rate, and sleep, as measured with a Fitbit (Sense).


Locations(1)

Cedars-Sinai Medical Center

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05391217


Related Trials